1. A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Issue 4 (6th January 2014) Authors: Jones, M. P.; Chey, W. D.; Singh, S.; Gong, H.; Shringarpure, R.; Hoe, N.; Chuang, E.; Talley, N. J. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 4(2014) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study. (February 2020) Authors: Anstee, Q.M.; Harrison, S.; Sanyal, Arun J.; Ratziu, V.; Rinella, M.; Younossi, Z.Y.; Boursier, J.; Francque, S.; Geerts, A.; Petta, S.; Bugianesi, E-; Romero-Gomez, M.; Schattenberg, J.M.; Sarkar, S.; Bonacini, M.; Yataco, M.; Porayko, M.; Siddique, A.; Dufour, J.; Ferro, T. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Obeticholic acid demonstrates sustained improvements at month 24 in transaminases and non-invasive markers of fibrosis: Results of a post hoc analysis from the interim analysis of the REGENERATE study. (March 2021) Authors: Loomba, R.; Ratziu, V.; Anstee, Q.M.; Harrison, S.; Sanyal, A.J.; Rinella, M.; Younossi, Z.Y.; Goodman, Z.; Bedossa, P.; Shringarpure, R.; Zhou, H.; Noureddin, M.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Obeticholic Acid Treatment in Patients with Non-Alcoholic Steatohepatitis: A Secondary Analysis of the Regenerate Study Across Fibrosis Stages. (February 2020) Authors: Sanyal, A.J.; Ratziu, V.; Loomba, R.; Rinella, M.; Anstee, Q.M.; Goodman, Z.; Bedossa, P.; Khalili, M.; Boursier, J.; Stinton, L.; Marchesini, G.; Allison, M.; George, J.; Arkkila, P.; Bugianesi, E.; Zaru, L.; MacConell, L.; Shringarpure, R. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC.05.5 OBETICHOLIC ACID TREATMENT IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A SECONDARY ANALYSIS OF THE REGENERATE STUDY ACROSS FIBROSIS STAGES. (1st October 2020) Authors: Sanyal, A.J.; Ratziu, V.; Loomba, R.; Rinella, M.; Anstee, Q.M.; Goodman, Z.; Bedossa, P.; Khalili, M.; Boursier, J.; Stinton, L.; Marchesini, G.; Allison, M.; George, J.; Arkkila, P.; Bugianesi, E.; Zaru, L.; Macconell, L.; Shringarpure, R.; Younossi, Z. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. T06.01.12 OBETICHOLIC ACID (OCA) IMPROVES NON-INVASIVE MARKERS OF FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH): A SECONDARY ANALYSIS OF THE PHASE 3 REGENERATE STUDY. (1st October 2020) Authors: Anstee, Q.M.; Harrison, S.; Sanyal, A.J.; Ratziu, V.; Rinella, M.; Younossi, Z.Y.; Boursier, J.; Francque, S.; Geerts, A.; Petta, S.; Bugianesi, E.; Romero-Gomez, M.; Schattenberg, J.M.; Sarkar, S.; Bonacini, M.; Yataco, M.; Porayko, M.; Siddique, A.; Dufour, J.; Ferro, T. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗